Literature DB >> 16265961

[How I treat ... lentigo maligna by topical imiquimod].

R Bourguignon1, P Paquet, P Quatresooz, G E Piérard.   

Abstract

Lentigo maligna is a special form of in situ cutaneous melanoma that develops on the face of sun worshipers. The topic immunostimulator imiquimod can destroy the neoplasm before it expresses its invasive potential. A strict clinical follow-up of the treated zone must be observed at least 5 years to detect any early sign of recurrence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16265961

Source DB:  PubMed          Journal:  Rev Med Liege        ISSN: 0370-629X


  1 in total

1.  Observational study of topical imiquimod immunotherapy in the treatment of difficult lentigo maligna.

Authors:  E E Craythorne; C M Lawrence
Journal:  Clin Med Oncol       Date:  2008-12-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.